Metabolism Flashcards

1
Q

Primary lactose intolerance

A

Age-dependent decline after childhood (absence of lactase-persistent allele)
Common in people of Asian, African or NA descent
Intestinal biopsy reveals normal mucosa in pts with hereditary lactose intolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Secondary lactose intolerance

A

Loss of brush boarder enzyme due to gastroenteritis (e.g. Rotavirus), autoimmune disease, etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Congenital lactose intolerance

A

Rare, but due to a defective gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Urea Cycle

A

Amino acid catabolism results in the formation of common metabolite (e.g. Pyre ate, actual-CoA) which serve as metabolic fuels
Excess nitrogen (NH3) generate by this process is converted to urea and excreted by kidneys
Ordinarily (Ornithine), Careless (Carbomoyl Phosphate) Crappers (Citruline) Are (Aspartate) Also (Arginosuccinate) Frivolous (Fumarate) About (Arginine) Urination (Urea)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Hyperammonemia

A

Can be acquired (e.g. Liver disease) or hereditary (urea cycle enzyme deficiencies)
Results in excess NH3 which depletes alpha-KG, leading to inhibition of the TCA cycle
Clinical findings: tremor (asterixis), slurring of speech, somnolence, vomiting, cerebral edema, blurring of vision

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Treatment of Hyperammonemia

A

Treatment to decrease ammonia levels:
lactose to acidity the GI tract and trap NH4+ for excretion
Rifaximin to decrease colonic ammoniagenic bacteria
Benzoate, phenyl acetate or phenyl iterate to bind NH4+ and lead to excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Glycogen: Skeletal muscle

A

Glycogen undergoes glyconeolysis to glucose 1-phosphate to glucose 6 phosphate, which is rapidly metabolized during exercise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Glycogen

A

Storage form of glucose
Branches have alpha (1-6) bonds
Linkages have alpha (1-4) bonds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Glycogen: hepatocytes

A

Stored and undergoes glyconeolysis to maintain blood sugar at appropriate levels
Glycogen phosphorylase liberates glucose 1-phosphate residues off branched glycogen until four glucose units remain on a branch
Then 4-alpha-glucanotransferase moves three molecules of glucose 1-phosphate from branch to the linkage
Then alpha-1,6-glycosidase cleaves off the last residue, liberating glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Fatty Acid Metabolism

A

Fatty acid synthesis requires transport of citrate from mitochondria to cytoskeleton
Predominantly occurs in liver, lactating mammary glands and adipose tissue
Long chain FA degradation requires carnitine-dependent transport into the mitochondrial matrix

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Ketone bodies

A

Ketones: acetone, acetoacetate, beta-hydroxybutyrate
In the liver FAs and AAs are metabolized to acetoacetate and beta-HB to be used by muscle and brain
In prolonged starvation and DKA, oxaloacetate is depleted for glyconeogeneis
In alcoholism, excess NADH shuts oxaloacetate to maleate
Both processes cause a build up of acetyl-CoA, which shunts glucose and FFA toward the production of ketone bodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Fed State

A

Glycolysis and aerobic respiration

Insulin stimulates storage of lipids, proteins and glycogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Fasting

A
Hepatic glycogenolysis (major); hepatic glyconeogeneis, adipose release of FFA (minor)
Glucagon and Epi stimulate use of fuel reserves
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Starvation days 1-3

A

Blood glucose levels maintained by:
Hepatic glycogenolysis
Adipose release of FFA
Muscle & liver which shift fuel use from glucose to FFA
Hepatic glyconeogenesis from peripheral tissue lactate and alanine and from adipose tissue glycerol and propionyl-CoA
Glycogen reserves depleted after day 1
RBCs lack mitochondria and therefore cannot use ketones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Starvation after day 3

A

Adipose stores (ketone bodies become main source of energy for the brain).
After these are depleted, vital protein degradation accelerates, leading to organ failure and death
Amount of excess stores determines survival time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Apolipoprotein E

A

Mediates remnant uptake

Present in chylomicron, chylomicron remnant, VLDL, IDL and HDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Apolipoprotein A-I

A

Activates LCAT

Present in: chylomicron and HDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Apolipoprotein C-II

A

Lipoprotein lipase co-factor

Present in Chylomicron, HDL and VLDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Apolipoprotein B-48

A

Mediates chylomicron secretion

Present in chylomicron so, chylomicron remnant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Apolipoprotein B-100

A

Binds LDL receptor

Present in VLDL, IDL and LDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Lipoprotein functions

A

Lipoproteins are composed of varying proportions of cholesterol, TGs, and phospholipids
LDL and HDL carry the most cholesterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

LDL

A

transports cholesterol from liver to tissues
LDL is Lousy
Formed by hepatic lipase modification of IDL in the liver and peripheral tissue
Taken up by target cells via receptor mediated endocytic is

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

HDL

A

Transports cholesterol from the periphery to liver
HDL is Healthy
Mediates reverse cholesterol transport. Acts as repository for apolipoproteins C & E (which are needed for chylomicron and VLDL metabolism)
Secreted from both liver and intestine
alcohol increases synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Chylomicron

A

Delivers dietary TGs to peripheral tissue
Delivers cholesterol to liver in the form of chylomicron remnants, which are mostly depleted of their TGs
Secreted by intestinal epithelial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

VLDL

A

Delivers hepatic TGs to peripheral tissue

Secreted by liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

IDL

A

Formed in the degradation of VLDL

Delivers TG and cholesterol to the liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Lactase decificiency

A

Insufficient lactase enzyme leading to dietary lactose intolerance
Lactase functions on the brush border to digest lactose into glucose and galactose
Stool demonstrates a decreased pH and breath shows increased H content with lactose hydrogen breath test
Findings: Bloating, cramps, flatulence, osmotic diarrhea
Treatment: avoid dairy products or add lactase pills to diet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Ethanol metabolism

A

Ethanol – alcohol dehydrogenase –acetaldehyde
Acetaldehyde – acetaldehyde dehydrogenase – acetate
Both steps require NAD+ to NADH (NAD+ is the limiting reagent)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Alcohol dehydrogenase

A

Zero order kinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Fomepizole

A

Inhibits alcohol dehydrogenase and is an antidote for methanol or ethylene glycol poisoning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Disulfiram

A

Inhibits acetaldehyde dehydrogenase

Acetaldehyde accumulates contributing to hangover symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Ethanol metabolism Increase NADH/NAD+ ratio

A

Causes:
Pyruvate to lactate conversion (lactic acidosis)
Oxaloacetate to malate (prevents gluconeogenesis- fasting hypoglycemia)
Dihydroxyacetone phosphate to glycerol-3-phosphate (combines with FAs to make TGs - hepatosteatosis)
Disfavors TCA production of NADH - increased utilization of acetyl-CoA for ketogenesis (ketoacidosis) and lips genesis (hepatosteatosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Metabolism: Mitochondria

A

FA oxidation (beta-oxidation), acetyl-CoA production, TCA cycle, oxidative phosphorylation, ketogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Metabolism: Cytoplasm

A

Glycolysis, HMP shunt, and synthesis of steroids (SER), proteins (ribosomes, RER), FAs, cholesterol and nucleotides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Metabolism: Both mitochondria and cytoplasm

A

Heme synthesis, urea cycle, gluconeogenesis

HUGs take two (i.e. Both)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Kinase

A

Catalyzes transfer of a phosphate group from a high energy molecule (usually ATP) to a substrate (eg phosphofructokinase)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Phosphorylase

A

Adds inorganic phosphate onto a substrate without using ATP (eg glycogen phosphorylase)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Phosphatase

A

Removes phosphate onto substrate (eg fructose 1,6 bisphosphatase)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Dehydrogenase

A

Catalyzes oxidation-reduction reactions (eg pyruvate dehydrogenase)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Hydroxylase

A

Adds hydroxyl group (OH) onto substrate (e.g. Tyrosine hydroxylase)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Carboxylase

A

Transfers CO2 groups with help of biotin (pyruvate carboxylase)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Mutase

A

Relocates a functional group within a molecule (eg vitamin B12 dependent methylmalonyl-CoA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Rate Determining enzyme: glycolysis

A

Enzyme: phosphofructokinase-1 (PFK-1)
Regulators: AMP (+), fructose-2,6-bisphosphate (+), ATP (-), citrate (-)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Rate Determining enzyme: Gluconeogenesis

A

Enzyme: Fructose 1,6, bisphosphate
Regulators: AMP (-), fructose 2,6-bisphosphate (-)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Rate Determining enzyme: TCA cycle

A

Enzyme: Isocitrate dehydrogenase
Regulators: ADP (+), ATP (-), NADH (-)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Rate Determining enzyme: Glycogenesis

A

Enzyme: glycogen synthase
Regulators: glucose-6-phosphate (+), insulin (+), cortisol (+), Epi (-), glucagon (-)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Rate Determining enzyme: Glycogenolysis

A

Enzyme: glycogen phosphorylase
Regulators: Epi (+), glucagon (+), AMP (+), glucose-6-phosphate (-), insulin (-), ATP (-)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Rate Determining enzyme: HMP shunt

A

Enzyme: glucose-6-phosphate dehydrogenase
Regulators: NADP+ (+), NADPH (-)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Rate Determining enzyme: De novo pyrimidine synthesis

A

Enzyme: carbamoyl phosphate synthetase II
Regulators: ATP (+), PRPP (+), UTP (-)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Rate Determining enzyme: De novo purine synthesis

A

Enzyme: glutamine phosphoribosylpyrophosphate (PRPP) amindotransferase
Regulators: AMP (-), inosine monophosphate (IMP) (-), GMP (-)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Rate Determining enzyme: Urea cycle

A

Enzyme: carbamoyl phosphate synthetase I
Regulators: N-acetylglutamate (+)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Rate Determining enzyme: FA synthesis

A

Enzyme: acetyl-CoA carboxylase (ACG)
Regulators: insulin (+), citrate (+), glucagon (-), palmitoyl-CoA (-)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Rate Determining enzyme: FA oxidation

A

Enzyme: carnitine acyltransferase I
Regulators: Malonyl-CoA (-)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

Rate Determining enzyme: Ketogenesis

A

Enzyme: HMG-CoA synthase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Rate Determining enzyme: Cholesterol synthesis

A

Enzyme: HMG-CoA reductase
Regulators: insulin (+), thyroxin (+), glucagon (-), cholesterol (-)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

ATP production

A

Aerobic metabolism of glucose produces 32 net ATP via malate-aspartate shuttle (heart and liver)
30 net ATP via glycerol-3-phosphate shuttle (muscle)
Anaerobic glycolysis produces only 2 net ATP per glucose molecule
ATP hydrolysis can be coupled to energetically unfavorable reactions
Arsenic causes glycolysis to produce 0 ATP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Activated carriers

A
ATP: phosphoryl groups
NADH, NADPH, FADH2: electrons
CoA, lipoamide: Acyl groups
Biotin: CO2
Tetrahydrofolates: 1-carbon units
S-adenosylmethionine (SAM): CH3 groups
TTP: aldehydes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

Universal electron acceptors

A

Nicotinamides (NAD+ from VitB3, NADP+)
NAD+ is generally used in catabolic processes to carry reducing equivalents away as NADH
NADPH (product of HMP shunt) is used in anabolic processes (steroid and FA synthesis) as a supply of reducing equivalents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

Uses of NADPH

A

Anabolic processes
Respiratory burst
Cytochrome P-450 system
Glutathione reductase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

First committed step of glycolysis

A

Phosphorylation of glucose to yield glucose-6-phosphate
Reaction is either catalyzes by hexokinase or glucokinase, depending on the tissue
At low glucose concentrations hexokinase sequesters glucose in the tissue. At high glucose concentrations excess glucose is stored in the liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

Hexokinase

A
Location: most tissues, except liver and pancreatic beta cells
Km: lower (increased affinity)
Vmax: lower (decreased capacity)
Induced by insulin: No
Feedback inhibited by G6P: Yes
Gene mutation associate with MODY: No
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

Glucokinase

A
Location: liver, beta cells of pancreas
Km: higher (decreased affinity)
Vmax: higher (increased capacity)
Induced by insulin: yes
Feedback inhibited by G6P: No
Gene mutation associated with MODY: yes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

Glycolysis regulation

A
Net glycolysis (cytoplasm)
Glucose + 2Pi + 2ADP + 2NAD+ -- 2 pyruvate + 2ATP + 2NADH + 2H+ + 2H2O
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

Key enzymes in glycolysis that require ATP

A

Hexokinase/glucokinase (glucose to G6P)

Phosphofructokinase-1 (Fructose 6-phosphate to Fructose 1,6 BP)

65
Q

Key enzymes in glycolysis that produce ATP

A
Phosphoglycerate kinase (1,3 BPG to 3 PG)
Pyruvate kinase (phosphoenolpyruvate to pyruvate)
66
Q

Sorbitol

A

An alternative method of trapping glucose in the cell s to convert it to its alcohol counterpart (sorbitol) via aldose reductase
Some tissues convert sorbitol into fructose using sorbitol dehydrogenase (liver, ovaries, seminal vesicles)
Tissue with an insufficient amount/activity (Schwann cells, retina, kidney, lens) of this enzyme are at risk for intracellular sorbitol accumulation, causing osmotic damage (eg cataracts, retinopathy and peripheral neuropathy seen with chronic hyperglycemia in diabetic pts)

67
Q

Essential Amino Acids

A

Glucogenic: methionine (Met), valine (Val), histidine (His)
Glucogenic/ketogenic: isoleucine (Ile), phenylalanine (Phe), Threonine (Thr), tryptophan (Trp)
Ketogenic: Leucine (Leu), Lysine (Lys)

68
Q

Acidic Amino Acids

A
Aspartic acid (Asp) and glutamic acid (Glu)
Negatively charged at body pH
69
Q

Basic Amino Acids

A

Arginine (Arg) - most basic, lysine (Lys), histidine (His)-no charge at body pH
Arg & His are required during periods of growth
Arg & Lys are increased in his tones, which bind negatively charged DNA

70
Q

N-acetylglutamate synthase deficiency

A

Required cofactor for carbamoyl phosphate synthetase I. Absence of N-acetylglutamate = Hyperammonemia
Presents in neonates as poorly regulated respiration and body temp, poor feeding, developmental delay, intellectual disability (identical to presentation of carbamoyl phosphate synthetase I deficiency)

71
Q

Ornithine transcarbamylase deficiency

A

Most common urea cycle disorder (X-linked recessive - all other urea cycle disorders are AR)
Interferes with the body’s ability to eliminate ammonia, often evident in first few days of life, but may present later. Excess carbamoyl phosphate is converted to orotic acid (part of the Pyrimidine synthesis pathway)
Findings: increased orotic acid in blood and urine, decreased BUN, symptoms of Hyperammonemia, no megaloblastic anemia (vs. orotic aciduria)

72
Q

Amino Acid derivatives: Phenylalanine

A

Phenylalanine –> Tryosine –> Dopa –> Dopamine –> NE –> Epi
Phenylalanine –> Tyrosine –> Thyroxine
Phenylalanine –> Tyrosine –> Dopa –> Melanin

73
Q

Amino Acid derivatives: Tryptophan

A

Tryptophan –> Niacin –> NAD+/NADP+

Tryptophan –> Serotonin –> Melatonin

74
Q

Amino Acid derivatives: Histidine

A

Histidine –> Histamine

75
Q

Amino Acid derivatives: Glycine

A

Glycine –> porphyrin –> heme

76
Q

Amino Acid derivatives: Glutamate

A

Glutamate –> GABA

Glutamate –> Glutathione

77
Q

Amino Acid derivatives: Arginine

A

Arginine –> Creatine
Arginine –> Urea
Arginine –> Nitric Oxide

78
Q

Phenylkentonuria

A

AR
Due to decreased phenylalanine hydroxylase or decreased tetrahydrobiopterin cofactor (malignant PKU). Tyrosine becomes essential
Increased phenylalanine –> excess phenylketonuria in urine
Findings: intellectual disability, growth retardation, seizures, fair skin, eczema, musty body odor (disorder of AROMATIC amino acid metabolism - musty body ODOR)
Tx: decrease Phe and increase Tyr in diet, tetrahydrobiopterin supplementation

79
Q

Maternal PKU

A

Lack of proper dietary therapy during pregnancy

Findings in infant: microcephaly, intellectual disability, growth retardation, congenital heart defects

80
Q

Male Syrup Urine disease

A

Blocked degradation of branched amino acids (AR) - Isoleucine, Leucine, Valine due to decreased branched-chain alpha-ketoacid dehydrogenase (B1). Causes increase in alpha-ketoacids in blood
Causes severe CNS defects, intellectual disability and death; presents with vomiting, poor feeding, urine that smells sweet
Tx: restriction of Iso, Leu, Val in diet and thiamine supplementation
(I Love Vermont MAPLE SYRUP from maple trees with B1ranches)

81
Q

Alkaptonuria

A

Congenital deficiency of homogentisate oxidase (AR) in the degradation pathway of tyrosine to Fumarate –> pigment-forming homogentistic acid accumulates in tissue
Findings: bluish-black CT and sclerae (ochronosis); urine turns black on prolonged exposure to air. May have debilitating arthralgias (homogentistic acid toxic to cartilage)

82
Q

Homocystinuria: findings

A

All forms result in excess homocysteine
Findings: increased homocysteine in urine, intellectual disability, osteoporosis, marfanoid habitus, kyphosis, lens subluxation (downward and inward), thrombosis, atherosclerosis (stroke/MI)

83
Q

Homocystinuria: Types

A
  1. Cystathionine synthase deficiency (tx: decrease Met, increase cysteine, increase B12 & folate in diet
  2. decreased affinity of cystathionine synthase for pyridoxal phosphate (tx: highly increase B6 and increase cysteine in diet)
  3. Methionine synthase (homocysteine methyltransferase) deficiency (tx: increase Met in diet)
84
Q

Cystinuria

A

Hereditary defect (AR) of renal PCT and intestinal AA transporter that prevents reabsorption of Cystine, Ornithine, Lysine, Arginine (COLA)
Excess cystine in the urine can lead to recurrent precipitation of hexagonal cystine stones
Diagnosis: urinary cyanide-nitroprusside test positive
Tx: urinary alkali inaction (e.g. K citrate, acetazolamide) and chelating agents (penicillamine) to increase solubility of cystine stones; good hydration

85
Q

Glycogen: skeletal muscle

A

Branches have alpha-1,6 bonds; linkages have alpha-1,4 bonds
Glycogen undergoes glycogenolysis –> glucose-1-phosphate –> glucose-6-phosphate
G6P is rapidly metabolized during exercise

86
Q

Glycogen: Hepatocytes

A

Branches have alpha-1,6 bonds; linkages have alpha-1,4 bonds
Glycogen is stored and undergoes glycogenolysis to maintain blood sugar at appropriate levels
Glycogen phosphorylase liberates glucose-1-phosphate residues off branched glycogen until 4 glucose remain on a branch –> 4-alpha-D-glucanotransferase (debranching enzyme) moves three molecules of glucose of G1P from branch to linkage –> alpha-1,6-glucosidase cleaves off the last residue, liberating glucose

87
Q

Glycogen Storage diseases

A

Abnormal glycogen metabolism and an accumulation of glycogen within the cells
Periodic acid-Schiff stain identifies glycogen and is useful in identification
Very Poor Carbohydrate Metabolism
Types I, II, III, & V are AR

88
Q

Von Gierke Disease (type I)

A

Severe fasting hypoglycemia
Very highly Increased Glycogen in liver, increased blood lactate, increased TGs and uric acid (Gout), hepatomegaly
Glucose-6-phosphatase deficiency - impaired gluconeogenesis and glycogenolysis
(Gs of Gierke - Glycogen & Gout due to Glucose-6-phosphatase)
Tx: frequent oral glucose/cornstarch, avoidance of fructose and galactose

89
Q

Pompe Disease (type II)

A

Cardiomegaly, hypertrophic cardiomyopathy, exercise intolerance, systemic findings leading to early death
Lysosomal alpha-1,4-glucosidase with alpha-1,6-glucosidase activity (acid maltase) deficiency.
Pompe trashes the Pump (heart, liver, muscle)

90
Q

Cori disease (type III)

A

Milder form of Von Gierke with normal blood lactate levels. Accumulation of limit dextrin-like structures in cytosol.
Deficient debranching enzyme (alpha-1,6-glucosidase)
Gluconeogenesis is intact

91
Q

McArdle disease (type V)

A

Increased glycogen in muscle but muscle cannot break it down –> painful muscle cramps, myoglobinuria (red urine) with strenuous exercise, and arrhythmia from electrolyte abnormalities. Second wind phenomenon noted during exercise duet to increased muscular blood flow
Deficient skeletal muscle phosphorylase (Myophosphorylase)
Blood glucose levels typically unaffected
(*The Ms of McArdle’s - Muscle cramps, Myoglobiuria, Myophosphorylase)

92
Q

Lysosomal Storage Disease: Fabry disease

A

Sphingolipidoses
Findings: (early): triad of episodic peripheral neuropathy, angiokeratomas, hypohidrosis (late): progressive renal failure, CVD
Deficiency: alpha-galactosidase A
Accumulated substrate: Ceramide Trihexoside
Inheritance: XR

93
Q

Lysosomal Storage Disease: Gaucher disease

A

Sphinolipidoses
Findings: (most common) hepatospenomegaly, panctyopenia, osteoporosis, aseptic necrosis of femur, bone crisis, Guacher cells (lipid-laden MP resembling tissue paper)
Deficiency: glucocerebrosidase (beta-glucosidase); treat with recombinant glucocerebrosidase
Accumulated substrate: glucocerebrosidase
Inheritance: AR

94
Q

Lysosomal Storage Disease: Niemann-Pick disease

A
Sphingolipidoses
Findings: Progressive neurodegeneration, hepatospenomegaly, foam cells (lipid laden MPs), cherry red spot on macula
Deficiency: sphingomyelinase
Accumulated substrate: sphingomyelin 
Inheritance: AR
95
Q

Lysosomal Storage Disease: Tay-Sachs disease

A
Sphingolipioses 
Findings: progressive neurodegeneration, developmental delay, cherry red spot on macula, lysosomes with onion skin, no hepatospenomegaly (vs. Neimann-Pick)
Deficiency: hexoaminidase A
accumulated substrate: GM2 ganglioside
Inheritance: AR
96
Q

Lysosomal Storage Disease: Krabbe disease

A

Sphingolipioses
Findings: peripheral neuropathy, developmental delay, optic atrophy, globoid cells
Deficiency: glactocerebrosidase
Accumulated substrate: galactocerebroside, psychosine
Inheritance: AR

97
Q

Lysosomal Storage Disease: Metachromatic Leukodystrophy

A

Sphingolipioses
Findings: Central and peripheral demyelination with ataxia, dementia
Deficiency: arylsulfatase A
Accumulated substrate: cerebroside sulfate
Inheritance: AR

98
Q

Lysosomal Storage Disease: Hurler syndrome

A

Mucopolysaccharidoses
Findings: developmental delay, gargoylism, airway obstruction, corneal clouding, hepatospenomegaly
Deficiency: alpha-L-iduronidase
Accumulated substrate: heparan sulfate, dermatan sulfate
Inheritance: AR

99
Q

Lysosomal Storage Disease: Hunter syndrome

A

Mucopolysaccharidoses
Findings: mild hurler + aggressive behavior, no corneal clouding
Deficiency: iduronate sulfatase
Accumulated substrate: heparan sulfate, dermatan sulfate
Inheritance: XR

100
Q

How to remember Lysosomal storage diseases

A

No man picks (Niemann-Pick) his nose with his sphinger (sphingomyelinase)
Tay-SaX lacks heXosaminidase
Hunters see clearly (no corneal clouding) and aggressively aim for the X (X-linked recessive)

101
Q

Fatty Acid metabolism

A

FA synthesis requires transport of citrate from mitochondria to cytosol. Predominantly occurs in liver, lactating mammary glands, and adipose tissue
LCFA degradation requires carnitine-dependent transport into the mitochondrial matrix
SYtrate = SYnthesis
CARnintine = CARnage of fatty acids

102
Q

Systemic primary carnitine deficiency

A

Inherited defect in transport of LCFAs into the mitochondria –> toxic accumulation
Causes weakness, hypotonia, hypoketotic hypoglycemia

103
Q

Medium chain acyl-CoA dehydrogenase deficiency

A

AR disorder of FA oxidation
Decreased ability to break down FAs into acetyl-CoA –> accumulation of 8 to 10 carbon fatty acyl carnitines in the blood and hypoketotic hypoglycemia
May present in infancy or early childhood with vomiting, lethargy, seizures, coma and liver dysfunction.
Minor illness can lead to sudden death. Treat by avoiding fasting.

104
Q

Ketone bodies

A

Acetone, acetoacetate, beta-hydroxybuterate
In the liver FAs and AAs are metabolized to acetoacetate and beta-hydroxybuterate (to be used by muscle and brain)
In prolonged starvation and diabetic ketoacidosis, oxaloacetate is depleted for gluconeogenesis. (Breath smells like acetone - fruity; can detect acetoacetate in the urine)

105
Q

Ketone bodies: alcoholism

A

Excess NADH shunts oxaloacetate to malate. Both DKA and alcoholism cause a build up of acetyl-CoA, which shunts glucose and FFA toward the production of ketone bodies

106
Q

Metabolic Fuel Use

A

1g of protein or carbohydrate = 4kcal
1g fat = 9 kcal
1g alcohol = 7kcal

107
Q

Fed State

A

Glycolysis and aerobic respiration

Insulin stimulates storage of lipids, proteins and glycogen

108
Q

Fasting (between meals)

A
Hepatic glycogenolysis (major), hepatic gluconeogenesis, adipose release of FFA (minor)
Glucagon and Epi stimulate use of fuel reserves
109
Q

Starvation (day 1-3)

A

Blood glucose levels maintained by
-hepatic glycogenolysis
-adipose release of FFA
-muscle and liver, which shift fuel use from glucose to FFA
-hepatic gluconeogenesis from peripheral tissue lactate and alanine and from adipose tissue glycerol and propionyl-CoA
Glycogen reserves are depleted after day one
RBCs lack mitochondria and therefore cannot use ketones

110
Q

Starvation (after day 3)

A

Adipose stores (ketone bodies become the main source of energy for the brain)
After these are depleted, vital protein degradation accelerates leading to organ failure and death
Amount of excess stores determines survival time

111
Q

Cholesterol synthesis

A

Needed to maintain cell membrane integrity and to synthesize bile acid, steroids and VitD
Rate-limiting step catalyzes by HMG-CoA reductase (induced by insulin) which converts HMG-CoA to mevalonate
2/3 of plasma cholesterol esterified by lecithin-cholesterol acyltransferase (LCAT)
Statins - competitively and reversibly inhibit HMG-CoA reductase

112
Q

Key Lipid enzymes & Transport: Pancreatic lipase

A

Degradation of dietary TGs in SI

113
Q

Key Lipid enzymes & Transport: Lipoprotein Lipase (LPL)

A

Degradation of TGs circulating in chylomicrons and VLDLs found on vascular endothelial surface

114
Q

Key Lipid enzymes & Transport: Hepatic TG Lipase (HL)

A

Degradation of TGs remaining in IDL

115
Q

Key Lipid enzymes & Transport: Hormone-sensitive Lipase

A

Degradation of TGs stored in adipocytes

116
Q

Key Lipid enzymes & Transport: LCAT

A

Catalyzes esterification of cholesterol

117
Q

Key Lipid enzymes & Transport: Cholesterol ester transfer protein (CETP)

A

Mediates transfer of cholesterol esters to other lipoprotein particles

118
Q

Familial dyslipidemias: Type I - Hyperchylomicronemia

A

Inheritance: AR
Pathogenesis: lipoprotein lipase or apolipoprotein CII deficiency
-increased blood levels of chylomicrons, TG & cholesterol
Clinical: pancreatitis, hepatospenomegaly, and eruption/pruritic xanthomas (no increased risk for atherosclerosis)
Creamy layer in supernatant

119
Q

Familial dyslipidemias: Type IIa - familial hypercholesterolemia

A

Inheritance: AD
Pathogenesis: absent or defective LDL receptors
-increased levels of LDL or cholesterol
Heterozygotes have high cholesterol (300) and homozygotes levels of 700+
Accelerated atherosclerosis (may have MI before 20), tendon (Achilles) xanthomas, and corneal arcus

120
Q

Familial dyslipidemias: Type IV - hypertriglyceridemia

A

Inheritance: AD
Pathogenesis: hepatic overproduction of VLDL
-increased levels of VLDL, TG
Clinical: hypertriglyceridemia (>1000) can cause acute pancreatitis

121
Q

Sorbitol

A

An alternative method of trapping glucose in the cell s to convert it to its alcohol counterpart (sorbitol) via aldose reductase
Some tissues convert sorbitol into fructose using sorbitol dehydrogenase (liver, ovaries, seminal vesicles)
Tissue with an insufficient amount/activity (Schwann cells, retina, kidney, lens) of this enzyme are at risk for intracellular sorbitol accumulation, causing osmotic damage (eg cataracts, retinopathy and peripheral neuropathy seen with chronic hyperglycemia in diabetic pts)

122
Q

Essential Amino Acids

A

Glucogenic: methionine (Met), valine (Val), histidine (His)
Glucogenic/ketogenic: isoleucine (Ile), phenylalanine (Phe), Threonine (Thr), tryptophan (Trp)
Ketogenic: Leucine (Leu), Lysine (Lys)

123
Q

Acidic Amino Acids

A
Aspartic acid (Asp) and glutamic acid (Glu)
Negatively charged at body pH
124
Q

Basic Amino Acids

A

Arginine (Arg) - most basic, lysine (Lys), histidine (His)-no charge at body pH
Arg & His are required during periods of growth
Arg & Lys are increased in his tones, which bind negatively charged DNA

125
Q

N-acetylglutamate synthase deficiency

A

Required cofactor for carbamoyl phosphate synthetase I. Absence of N-acetylglutamate = Hyperammonemia
Presents in neonates as poorly regulated respiration and body temp, poor feeding, developmental delay, intellectual disability (identical to presentation of carbamoyl phosphate synthetase I deficiency)

126
Q

Ornithine transcarbamylase deficiency

A

Most common urea cycle disorder (X-linked recessive - all other urea cycle disorders are AR)
Interferes with the body’s ability to eliminate ammonia, often evident in first few days of life, but may present later. Excess carbamoyl phosphate is converted to orotic acid (part of the Pyrimidine synthesis pathway)
Findings: increased orotic acid in blood and urine, decreased BUN, symptoms of Hyperammonemia, no megaloblastic anemia (vs. orotic aciduria)

127
Q

Amino Acid derivatives: Phenylalanine

A

Phenylalanine –> Tryosine –> Dopa –> Dopamine –> NE –> Epi
Phenylalanine –> Tyrosine –> Thyroxine
Phenylalanine –> Tyrosine –> Dopa –> Melanin

128
Q

Amino Acid derivatives: Tryptophan

A

Tryptophan –> Niacin –> NAD+/NADP+

Tryptophan –> Serotonin –> Melatonin

129
Q

Amino Acid derivatives: Histidine

A

Histidine –> Histamine

130
Q

Amino Acid derivatives: Glycine

A

Glycine –> porphyrin –> heme

131
Q

Amino Acid derivatives: Glutamate

A

Glutamate –> GABA

Glutamate –> Glutathione

132
Q

Amino Acid derivatives: Arginine

A

Arginine –> Creatine
Arginine –> Urea
Arginine –> Nitric Oxide

133
Q

Phenylkentonuria

A

AR
Due to decreased phenylalanine hydroxylase or decreased tetrahydrobiopterin cofactor (malignant PKU). Tyrosine becomes essential
Increased phenylalanine –> excess phenylketonuria in urine
Findings: intellectual disability, growth retardation, seizures, fair skin, eczema, musty body odor (disorder of AROMATIC amino acid metabolism - musty body ODOR)
Tx: decrease Phe and increase Tyr in diet, tetrahydrobiopterin supplementation

134
Q

Maternal PKU

A

Lack of proper dietary therapy during pregnancy

Findings in infant: microcephaly, intellectual disability, growth retardation, congenital heart defects

135
Q

Male Syrup Urine disease

A

Blocked degradation of branched amino acids (AR) - Isoleucine, Leucine, Valine due to decreased branched-chain alpha-ketoacid dehydrogenase (B1). Causes increase in alpha-ketoacids in blood
Causes severe CNS defects, intellectual disability and death; presents with vomiting, poor feeding, urine that smells sweet
Tx: restriction of Iso, Leu, Val in diet and thiamine supplementation
(I Love Vermont MAPLE SYRUP from maple trees with B1ranches)

136
Q

Alkaptonuria

A

Congenital deficiency of homogentisate oxidase (AR) in the degradation pathway of tyrosine to Fumarate –> pigment-forming homogentistic acid accumulates in tissue
Findings: bluish-black CT and sclerae (ochronosis); urine turns black on prolonged exposure to air. May have debilitating arthralgias (homogentistic acid toxic to cartilage)

137
Q

Homocystinuria: findings

A

All forms result in excess homocysteine
Findings: increased homocysteine in urine, intellectual disability, osteoporosis, marfanoid habitus, kyphosis, lens subluxation (downward and inward), thrombosis, atherosclerosis (stroke/MI)

138
Q

Homocystinuria: Types

A
  1. Cystathionine synthase deficiency (tx: decrease Met, increase cysteine, increase B12 & folate in diet
  2. decreased affinity of cystathionine synthase for pyridoxal phosphate (tx: highly increase B6 and increase cysteine in diet)
  3. Methionine synthase (homocysteine methyltransferase) deficiency (tx: increase Met in diet)
139
Q

Cystinuria

A

Hereditary defect (AR) of renal PCT and intestinal AA transporter that prevents reabsorption of Cystine, Ornithine, Lysine, Arginine (COLA)
Excess cystine in the urine can lead to recurrent precipitation of hexagonal cystine stones
Diagnosis: urinary cyanide-nitroprusside test positive
Tx: urinary alkali inaction (e.g. K citrate, acetazolamide) and chelating agents (penicillamine) to increase solubility of cystine stones; good hydration

140
Q

Glycogen: skeletal muscle

A

Branches have alpha-1,6 bonds; linkages have alpha-1,4 bonds
Glycogen undergoes glycogenolysis –> glucose-1-phosphate –> glucose-6-phosphate
G6P is rapidly metabolized during exercise

141
Q

Glycogen: Hepatocytes

A

Branches have alpha-1,6 bonds; linkages have alpha-1,4 bonds
Glycogen is stored and undergoes glycogenolysis to maintain blood sugar at appropriate levels
Glycogen phosphorylase liberates glucose-1-phosphate residues off branched glycogen until 4 glucose remain on a branch –> 4-alpha-D-glucanotransferase (debranching enzyme) moves three molecules of glucose of G1P from branch to linkage –> alpha-1,6-glucosidase cleaves off the last residue, liberating glucose

142
Q

Glycogen Storage diseases

A

Abnormal glycogen metabolism and an accumulation of glycogen within the cells
Periodic acid-Schiff stain identifies glycogen and is useful in identification
Very Poor Carbohydrate Metabolism
Types I, II, III, & V are AR

143
Q

Von Gierke Disease (type I)

A

Severe fasting hypoglycemia
Very highly Increased Glycogen in liver, increased blood lactate, increased TGs and uric acid (Gout), hepatomegaly
Glucose-6-phosphatase deficiency - impaired gluconeogenesis and glycogenolysis
(Gs of Gierke - Glycogen & Gout due to Glucose-6-phosphatase)
Tx: frequent oral glucose/cornstarch, avoidance of fructose and galactose

144
Q

Pompe Disease (type II)

A

Cardiomegaly, hypertrophic cardiomyopathy, exercise intolerance, systemic findings leading to early death
Lysosomal alpha-1,4-glucosidase with alpha-1,6-glucosidase activity (acid maltase) deficiency.
Pompe trashes the Pump (heart, liver, muscle)

145
Q

Cori disease (type III)

A

Milder form of Von Gierke with normal blood lactate levels. Accumulation of limit dextrin-like structures in cytosol.
Deficient debranching enzyme (alpha-1,6-glucosidase)
Gluconeogenesis is intact

146
Q

McArdle disease (type V)

A

Increased glycogen in muscle but muscle cannot break it down –> painful muscle cramps, myoglobinuria (red urine) with strenuous exercise, and arrhythmia from electrolyte abnormalities. Second wind phenomenon noted during exercise duet to increased muscular blood flow
Deficient skeletal muscle phosphorylase (Myophosphorylase)
Blood glucose levels typically unaffected
(*The Ms of McArdle’s - Muscle cramps, Myoglobiuria, Myophosphorylase)

147
Q

Lysosomal Storage Disease: Fabry disease

A

Sphingolipidoses
Findings: (early): triad of episodic peripheral neuropathy, angiokeratomas, hypohidrosis (late): progressive renal failure, CVD
Deficiency: alpha-galactosidase A
Accumulated substrate: Ceramide Trihexoside
Inheritance: XR

148
Q

Lysosomal Storage Disease: Gaucher disease

A

Sphinolipidoses
Findings: (most common) hepatospenomegaly, panctyopenia, osteoporosis, aseptic necrosis of femur, bone crisis, Guacher cells (lipid-laden MP resembling tissue paper)
Deficiency: glucocerebrosidase (beta-glucosidase); treat with recombinant glucocerebrosidase
Accumulated substrate: glucocerebrosidase
Inheritance: AR

149
Q

Lysosomal Storage Disease: Niemann-Pick disease

A
Sphingolipidoses
Findings: Progressive neurodegeneration, hepatospenomegaly, foam cells (lipid laden MPs), cherry red spot on macula
Deficiency: sphingomyelinase
Accumulated substrate: sphingomyelin 
Inheritance: AR
150
Q

Lysosomal Storage Disease: Tay-Sachs disease

A
Sphingolipioses 
Findings: progressive neurodegeneration, developmental delay, cherry red spot on macula, lysosomes with onion skin, no hepatospenomegaly (vs. Neimann-Pick)
Deficiency: hexoaminidase A
accumulated substrate: GM2 ganglioside
Inheritance: AR
151
Q

Lysosomal Storage Disease: Krabbe disease

A

Sphingolipioses
Findings: peripheral neuropathy, developmental delay, optic atrophy, globoid cells
Deficiency: glactocerebrosidase
Accumulated substrate: galactocerebroside, psychosine
Inheritance: AR

152
Q

Lysosomal Storage Disease: Metachromatic Leukodystrophy

A

Sphingolipioses
Findings: Central and peripheral demyelination with ataxia, dementia
Deficiency: arylsulfatase A
Accumulated substrate: cerebroside sulfate
Inheritance: AR

153
Q

Lysosomal Storage Disease: Hurler syndrome

A

Mucopolysaccharidoses
Findings: developmental delay, gargoylism, airway obstruction, corneal clouding, hepatospenomegaly
Deficiency: alpha-L-iduronidase
Accumulated substrate: heparan sulfate, dermatan sulfate
Inheritance: AR

154
Q

Lysosomal Storage Disease: Hunter syndrome

A

Mucopolysaccharidoses
Findings: mild hurler + aggressive behavior, no corneal clouding
Deficiency: iduronate sulfatase
Accumulated substrate: heparan sulfate, dermatan sulfate
Inheritance: XR

155
Q

How to remember Lysosomal storage diseases

A

No man picks (Niemann-Pick) his nose with his sphinger (sphingomyelinase)
Tay-SaX lacks heXosaminidase
Hunters see clearly (no corneal clouding) and aggressively aim for the X (X-linked recessive)

156
Q

Fatty Acid metabolism

A

FA synthesis requires transport of citrate from mitochondria to cytosol. Predominantly occurs in liver, lactating mammary glands, and adipose tissue
LCFA degradation requires carnitine-dependent transport into the mitochondrial matrix
SYtrate = SYnthesis
CARnintine = CARnage of fatty acids

157
Q

Systemic primary carnitine deficiency

A

Inherited defect in transport of LCFAs into the mitochondria –> toxic accumulation
Causes weakness, hypotonia, hypoketotic hypoglycemia

158
Q

Medium chain acyl-CoA dehydrogenase deficiency

A

AR disorder of FA oxidation
Decreased ability to break down FAs into acetyl-CoA –> accumulation of 8 to 10 carbon fatty acyl carnitines in the blood and hypoketotic hypoglycemia
May present in infancy or early childhood with vomiting, lethargy, seizures, coma and liver dysfunction.
Minor illness can lead to sudden death. Treat by avoiding fasting.